STAT

JANUARY 18, 2024

Long Covid has long eluded scientists looking for its cause. Not knowing what triggers its persistent and distressing symptoms makes the condition challenging to treat; it’s hard to even say definitively who has it. New research published Thursday in Science has identified proteins present in the blood of people with long Covid that could point the way to a much-needed diagnostic test and possibly to future therapeutic targets.

Immunity 362

Immunity Immunization 362

Pharmacy Is Right For Me

JANUARY 18, 2024

A pharmacy education provides diverse opportunities, ranging from patient care and research to education. Truly, no one path looks the same and there is no better example than Dr. Lindsey Moseley who found her passion for teaching and education whilst pursuing her Pharm.D. degree. Facing An Identity Crisis Dr. Lindsey Moseley is the Curricular Coordinator and a faculty member at Auburn University Harrison College of Pharmacy.

246

246

STAT

JANUARY 18, 2024

For three days in December, an ICU room at the Hospital of the University of Pennsylvania bore witness to the first-ever merging of two powerful new technologies poised to change the future of transplant medicine. On a gurney, a brain-dead patient lay connected to a whirring Rube Goldberg-esque machine: a tangle of tubes and siphons on wheels. From a cannula on one end, blood from the patient entered, was pumped full of oxygen and other nutrients, then pushed into a cozy, temperature-controlled

Hospitals 358

Hospitals 358

PharmaVoice

JANUARY 18, 2024

Creative thinking is the name of the game as biopharmas seek to overcome a host of challenges — and investing with purpose, building trust and embracing tech could get them there.

130

130

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

JANUARY 18, 2024

Even though Erin Booth was not thrilled about having to travel to Philadelphia for a conference at six weeks postpartum, this one at least advertised having a private lactation space. This was back in 2013, when such accommodations were a rarity. The first bad sign was having to walk clear across the convention center to get there, cutting into her already brief pumping window.

358

358

The Pharmacist

JANUARY 18, 2024

Patient hesitancy and concerns about privacy could mean a slow uptake of Pharmacy First services, the head of policy, public affairs and research at Healthwatch England has warned. Speaking to the Health and Social Care Committee (HSCC)’s pharmacy inquiry this week, William Pett suggested that greater public awareness of pharmacy services was needed for patients […] The post Patients could be hesitant about Pharmacy First, warns Healthwatch England appeared first on The Pharmacist.

121

121

The Pharmacist

JANUARY 18, 2024

Negotiations for the 2024/25 contractual framework have been delayed due to last year’s ministerial reshuffle, it has been revealed. Discussions had still not begun as of 16 January, according to a blog post by Community Pharmacy England (CPE) chief executive Janet Morrison, who said she was expecting to hear from the Department of Health and […] The post CPE still waiting for contractual framework negotiations to start appeared first on The Pharmacist.

Community Pharmacies 103

Community Pharmacies 103

STAT

JANUARY 18, 2024

Timothy Stenzel, the federal regulator who led the Food and Drug Administration’s diagnostics division during the chaotic time of Covid-19 pandemic, has left the agency. The FDA confirmed Thursday that Stenzel, who led the FDA’s office of in vitro diagnostics, retired at the end of 2023.  During the early days of the pandemic, Stenzel was in the middle of a turf battle between the Centers for Disease Control and Prevention and the FDA over the regulation of Covid tests.

339

339

The Pharmacist

JANUARY 18, 2024

Community pharmacies in England must sign up with an IT supplier for Pharmacy First by Friday 19 January in order to be listed as providing the service when it launches in two weeks’ time. They must also sign up to provide Pharmacy First on the Manage Your Service (MYS) portal – which supports with reimbursement […] The post NHSE: Sign up to Pharmacy First IT by tomorrow in time for launch appeared first on The Pharmacist.

Community Pharmacies 110

Community Pharmacies 110

STAT

JANUARY 18, 2024

One morning last May, 10 students and two instructors from across California gathered on Zoom to talk about empathy. Empathy, said instructor Elizabeth Morrison, is often undervalued. But it’s a crucial skill for any effective mental health care provider. People who find their way into this academy, she said, tend to already have a lot of empathy and be good at communicating it.

Communication 325

Communication 325

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

The Pharmacist

JANUARY 18, 2024

Former Community Pharmacy Scotland (CPS) chief executive Harry McQuillan has taken up the position of chair at Numark. Phoenix UK, Numark’s parent company, said Mr McQuillan’s role would be to ‘help ensure policy makers across the UK understand fully the potential of community pharmacy’, as well as being ‘front and central’ in representing the interests […] The post Former CPS chief executive joins Numark as chair appeared first on The Pharmacist.

Community Pharmacies 105

Community Pharmacies 105

STAT

JANUARY 18, 2024

Microsoft on Thursday said it will launch its artificial intelligence tool for automating clinical documentation within health records software made by Epic, a move to embed the technology in health systems nationwide. The AI product, known as Dax Copilot, will automatically draft notes through Epic’s mobile application, known as Haiku, making it available for immediate review by clinicians.

Documentation 316

Documentation Hospitals 316

Pharmaceutical Commerce

JANUARY 18, 2024

In an interview with Pharma Commerce editor Nicholas Saraceno, Bill Roth, General Manager, Managing Partner, Blue Fin Group, discusses changes that will come with the pharma giant's new platform.

105

105

STAT

JANUARY 18, 2024

Amid a push to crack down on patent abuse by the pharmaceutical industry, a key U.S. lawmaker is urging six large drug companies to remove dozens of patents that were identified by regulators as improperly or inaccurately listed with a federal registry. In a series of letters sent on Thursday, Sen. Amy Klobuchar (D-Minn.) demanded the companies explain why they have, so far, not responded to warnings issued two months ago by the Federal Trade Commission to remove more than 100 patents from the r

309

309

BioPharma Dive

JANUARY 18, 2024

The company said it has secured agreement from labor representatives in Germany for job cuts that will shed “many managerial employees.

117

117

STAT

JANUARY 18, 2024

For years, the playbook for many companies that wanted to market digital therapeutics was stupid simple: Sell it like a prescription drug. But just because it was simple didn’t mean it was going to work. The bankruptcy of Pear Therapeutics last year proved that selling software-based treatments like drugs is harder than anticipated. Pear received Food and Drug Administration clearance for its app treating substance use disorders and insomnia but insurers mostly refused to cover the novel

282

282

pharmaphorum

JANUARY 18, 2024

Pfizer’s PARP inhibitor Talzenna has become the first targeted treatment for HER2-negative locally advanced or metastatic breast cancer with BRCA1/2 mutations to be recommended by NICE for routine NHS use.

102

102

STAT

JANUARY 18, 2024

Apple will remove the blood oxygen measurement feature from its Apple Watches, the company announced Thursday. It’s the latest twist in a saga between Apple and medical device company Masimo. The International Trade Commission issued an import ban against Apple Watches in October after finding the blood oxygen feature too similar to Masimo’s.

279

279

European Pharmaceutical Review

JANUARY 18, 2024

An attractive destination for ATMP clinical trials Based on the Cell and Gene Therapy Catapult (CGT Catapult)’s recently published UK 2023 Advanced Therapy Medicinal Product (ATMP) Clinical Trials Database , the UK is an attractive location for ATMP clinical trials. This is largely due to the number of ongoing ATMP clinical trials in the UK remaining “largely stable” over the past three years.

99

99

STAT

JANUARY 18, 2024

Humana’s Medicare Advantage enrollees got care in the hospital and physician clinics way more often than the company predicted at the end of 2023, forcing the health insurance giant on Thursday to drastically slash its profit projections for both 2023 and 2024. Those higher medical costs will wipe away more than $775 million of profit that Humana had expected to bank for 2023.

Hospitals 247

Hospitals 247

BioPharma Dive

JANUARY 18, 2024

Called Advanced Medicine Partners, the new company will offer specialized cell and gene therapy manufacturing services to biotech and pharma clients.

109

109

STAT

JANUARY 18, 2024

Why are rich biotechs cutting costs? Has JPM Week already worn off? And what’s going to move markets in 2024? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Jason Mast joins us to discuss an emerging trend in biotech: Cash-rich startups are laying off employees and tweaking their strategies amid a tough market for venture capital.

242

242

pharmaphorum

JANUARY 18, 2024

Medtech company DermaSensor gets FDA approval for a handheld device, powered by AI, that can be used to detect skin cancer at the point of care

110

110

STAT

JANUARY 18, 2024

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.  Sign up here  to receive it in your inbox on Tuesdays and Thursdays. Inside Congress’ health care policy breakdown Lawmakers are headed toward passage of a stopgap spending bill that funds the same health programs as the last one — but things were almost different, I scooped last night.

237

237

pharmaphorum

JANUARY 18, 2024

This page explores the significant impact of artificial intelligence (AI) on the advancement of gene therapy development within the biopharmaceutical field.

104

104

STAT

JANUARY 18, 2024

In 2016, the 21 st Century Cures Act required that the U.S. make progress toward interoperability, which it defined as “all electronically accessible health information” to be accessed, exchanged and used “without special effort on the part of the user.” In December, seven years after the passage of the bill, the Department of Health and Human Services finalized a rule that will penalize providers for blocking access to electronic health information.

215

215

pharmaphorum

JANUARY 18, 2024

AI-powered patient risk assessment company C2-Ai and the Sickle Cell Society have won an NHS contest to find solutions that can tackle health inequality

104

104

STAT

JANUARY 18, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning, all. Damian here with a look at biotech’s early-year volatility, the debut of a new venture fund, and the perils of accepting reality.

Drug Pricing 200

Drug Pricing Drug Development 200

Express Pharma

JANUARY 18, 2024

Glenmark Life Sciences has signed a Master Supply Agreement (MSA) with a Japanese innovator pharma company. Under the aegis of the Master Supply Agreement, Glenmark Life Sciences will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the Japanese firm. As part of this collaboration, product portfolios of various affiliates of the Japanese company may also be added in the future.

98

98

STAT

JANUARY 18, 2024

The Edward M. Kennedy Academy for Health Careers will be revamped to create a guaranteed path to jobs at Mass General Brigham thanks to a multimillion investment from Bloomberg Philanthropies, the foundation announced Wednesday. The school, an in-district charter within Boston Public Schools, is one of 10 schools and districts around the country that will be funded by a new $250 million initiative.

Hospitals 190

Hospitals 190

Express Pharma

JANUARY 18, 2024

Lupin announced that it has received approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application for Febuxostat Tablets, 40 mg and 80 mg, to market a generic equivalent of Uloric Tablets, 40 mg and 80 mg, of Takeda Pharmaceuticals USA. The product will be manufactured at Lupin’s Pithampur facility in India.

95

95

World Pharma News

JANUARY 18, 2024

Pfizer Inc. (NYSE: PFE) announced that it has received notice of an unsolicited mini-tender offer by TRC Capital Investment Corporation of Ontario, Canada to purchase up to 4 million shares of Pfizer common stock at a price of $27.35 per share in cash. TRC Capital Investment's offer price of $27.35 per share is approximately 4.4 percent lower than the $28.61 closing share price of Pfizer's common stock on December 27, 2023 - the business day prior to the date of the offer.

91

91

pharmaphorum

JANUARY 18, 2024

pharmaphorum editor-in-chief Jonah Comstock is back from San Francisco, where he attended the annual JP Morgan Healthcare Conference. In today’s podcast episode, guest host Eloise McLennan interviews him about what he saw and heard at the show.

90

90

Outsourcing Pharma

JANUARY 18, 2024

Inceptua Group and Cycle Pharmaceuticals partnership will give access to Free Goods Partnership that gets medicine to patients with extremely rare genetic conditions, which they would be unable to access otherwise.

89

89

Express Pharma

JANUARY 18, 2024

The US FDA approved Casgevy, a cell-based gene therapy, for the treatment of patients 12 years of age and older with transfusion-dependent beta-thalassemia, an inherited disorder characterised by life-long anemia requiring frequent blood transfusions. To produce Casgevy, patients’ hematopoietic (blood) stem cells are modified by genome editing utilising novel CRISPR/Cas9 technology.

91

91